NEW YORK (dpa-AFX Broker) - Analysts Jefferies downgraded Drägerwerk from "hold" to "underperform" and lowered its price target from 42 to 36 euros. Due to the looming economic headwinds and persistent supply bottlenecks, he sees increasing risks for a short-term recovery of the medical technology company, analyst Henrik Paganetty wrote in a study published on Wednesday. He expects a disappointing fourth quarter due to increased cost pressures and cut his full-year 2022 earnings forecast (EPS) by just over half./edh/tih

Original publication date: 10.01.2023 / 15:48 / ET

First disclosure of original study: 10.01.2023 / 19:05 / ET

-----------------------

dpa-AFX Broker - Trader News from dpa-AFX

-----------------------